SZ 770 (Ropinirole hydrochloride extended-release 2 mg)

Pill imprint SZ 770 has been identified as Ropinirole hydrochloride extended-release 2 mg.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 2 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for SZ 770

Ropinirole hydrochloride extended-release
Imprint:
SZ
770
Strength:
2 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Inc.
National Drug Code (NDC):
00781-5780
Inactive Ingredients:
carboxymethylcellulose sodium
silicon dioxide
hydrogenated castor oil
hydroxypropyl cellulose
hypromelloses
ferric oxide red
lactose anhydrous
magnesium stearate
magnesium silicate
polyethylene glycol
ferrosoferric oxide
titanium dioxide
diethyl phthalate
maltodextrin
ethylcelluloses

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)